- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: July 2010
- Public Summary Document (PSD) July 2010 PBAC Meeting - PDF
Cetuximab – July 2010
CETUXIMAB, solution for I.V. infusion, 100 mg in 20 mL and 500 mg in 100 mL, Erbitux®
Last updated
19 October 2010